24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Diabetes
Resources
Basic InformationLatest News
Statins: Good for the Heart, Maybe Not So Good for DiabetesMedtronic Expands Recall Of Thousands of Insulin PumpsScientists Untangle Why Diabetes Might Raise Alzheimer's RiskWhat Blood Sugar Levels Best Protect Against Heart Trouble in Those With Diabetes?Osteoporosis Drug May Keep Type 2 Diabetes at BayIs Insulin Resistance a Recipe for Depression?Doctors Often Miss Signs of Type 1 Diabetes in KidsBlack Americans, Mexican Americans Develop Diabetes Earlier in LifeAHA News: How a Simple Tape Measure May Help Predict Diabetes in Black AdultsExpert Panel Lowers Routine Screening Age for Diabetes to 35Dangerous Diabetes Tied to Pregnancy Is on the RiseDiabetes in Pregnancy Tied to Eye Issues in KidsDiabetes-Linked Amputations: Your Race, State MattersDiet Key to Better Health in People With DiabetesWhen Deductibles Rise, More Diabetes Patients Skip Their MedsType 2 Diabetes in Teens Can Bring Dangerous Complications in 20sFDA OKs Automatic Use of a Cheaper Generic  InsulinAHA News: Diabetes and Dementia Risk: Another Good Reason to Keep Blood Sugar in CheckAmericans With Diabetes Were Hit Hard by COVID PandemicAHA News: The Challenge of Diabetes in the Black Community Needs Comprehensive SolutionsWhich Blood Sugar Meds Work Best Against Type 2 Diabetes?Walmart to Offer Low-Priced InsulinPoorly Managed Diabetes Raises Odds for More Severe COVIDWeekly Injected Drug Could Boost Outcomes for Patients With Type 2 DiabetesLockdown Weight Gain May Have Caused Surge in New Diabetes Cases in KidsAmerica Is Losing the War Against DiabetesA Fruitful Approach to Preventing DiabetesIn People With Type 1 Diabetes, Poor Blood Sugar Control Could Raise Dementia RiskBlood Sugar Tests Using Sweat, Not Blood? They Could Be on the WayWhen Diabetes Strikes in Pregnancy, Do Women Eat Healthier?Being a 'Night Owl' Raises Odds for Diabetes If You're Obese'Prediabetes' Raises Odds for Heart Attack, StrokeDementia Risk Rises as Years Lived With Type 2 Diabetes IncreasesCOVID-19 and Advanced Diabetes Can Be a Deadly Mix: StudyPandemic May Be Upping Cases of Severe Complication in Kids With DiabetesDiabetes Can Lead to Amputations, But Stem Cell Treatment Offers HopeCan a Drug Help Prevent Diabetic Vision Loss?Diabetes Is Deadlier for Black Americans: StudyLockdowns Gave Boost to Type 1 Diabetes Control in KidsComing Soon: Once-a-Week Insulin Injections?Common Type 2 Diabetes Meds Won't Raise Breast Cancer Risk: StudySome Kids With Type 1 Diabetes Face High Risk of Severe COVID-19Breakfast Timing Could Affect Your Odds for DiabetesBegin Routine Diabetes Screening at 35 for Overweight, Obese Americans: Task ForceCould a Drug Prevent Type 1 Diabetes in Those at Risk?Women With Type 1 Diabetes May Have Fewer Childbearing Years: StudyMeeting the Challenges of Type 1 Diabetes in the Teen YearsA Fifth of COVID Patients With Diabetes Die Within 1 Month of Hospitalization'Prediabetes' May Be Harming Your Brain, Study FindsDoes 'Prediabetes' Lead to Full-Blown Diabetes? Age May Be Key
Links
Related Topics

Medical Disorders

Walmart to Offer Low-Priced Insulin

HealthDay News
by Robert Preidt
Updated: Jun 29th 2021

new article illustration

TUESDAY, June 29, 2021 (HealthDay News) -- Walmart said Tuesday that it will start selling its own private brand of insulin at much lower prices than competing products.

Insulin prices have skyrocketed in recent years, making it unaffordable for some Americans with diabetes, according to CBS News.

"We know many people with diabetes struggle to manage the financial burden of this condition, and we are focused on helping by providing affordable solutions," Dr. Cheryl Pegus, executive vice president of Walmart Health & Wellness, said in a company news release.

Just three companies — Eli Lilly, Novo Nordisk and Sanofi — control 99% of the market, and there are no generic versions of the drug available.

Walmart's insulin will cost $72.88 per vial and $85.88 per FlexPen, which is 58% to 75% lower than other insulin products on the market. That will save patients $101 per branded vial and $251 per package of branded FlexPens, the company said in a statement, CBS News reported.

Novo Nordisk will make Walmart's private brand insulin.

In Walmart's statement, the American Diabetes Association's (ADA) chief executive officer said the group welcomed "all affordable solutions" to managing diabetes.

"Diabetes often comes with high medical costs, estimated around $9,601 per person per year," ADA CEO Tracey Brown told CBS News.

In response to the Walmart announcement, the nonprofit JDRF said more needs to be done to ensure everyone with diabetes has access to affordable insulin.

"The rising cost of insulin is a fundamental issue faced by those living with diabetes, and JDRF applauds this new effort," the JDRF said in a statement. "No one should die because they can't afford their insulin."

The steep rise in insulin prices has been criticized by patients and lawmakers. Some patients say that difficulty affording insulin has forced them to ration the drug or make risky decisions.

More information

Visit the American Diabetes Association for more on the skyrocketing costs of managing diabetes.


SOURCES: CBS News; Walmart, news release, June 29, 2021